These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19876924)

  • 1. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.
    Smith EM; Pawlita M; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP
    Int J Cancer; 2010 Jul; 127(1):111-7. PubMed ID: 19876924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus seropositivity and risks of head and neck cancer.
    Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
    Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
    Smith EM; Rubenstein LM; Ritchie JM; Lee JH; Haugen TH; Hamsikova E; Turek LP
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2087-96. PubMed ID: 18708401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Spector ME; Sacco AG; Bellile E; Taylor JMG; Jones T; Sun K; Brown WC; Birkeland AC; Bradford CR; Wolf GT; Prince ME; Moyer JS; Malloy K; Swiecicki P; Eisbruch A; McHugh JB; Chepeha DB; Rozek L; Worden FP
    Clin Cancer Res; 2017 Jun; 23(11):2723-2729. PubMed ID: 27872102
    [No Abstract]   [Full Text] [Related]  

  • 5. Markers of HPV infection and survival in patients with head and neck tumors.
    Koslabova E; Hamsikova E; Salakova M; Klozar J; Foltynova E; Salkova E; Rotnaglova E; Ludvikova V; Tachezy R
    Int J Cancer; 2013 Oct; 133(8):1832-9. PubMed ID: 23564321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
    Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
    Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and risk factors in patients with head and neck tumors.
    Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E
    J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
    Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
    Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Kiyuna A; Matayoshi S; Uehara T; Agena S; Yamashita Y; Ogawa K; Maeda H; Suzuki M
    Head Neck; 2013 Jun; 35(6):800-8. PubMed ID: 22791649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination.
    Smyth LJ; Van Poelgeest MI; Davidson EJ; Kwappenberg KM; Burt D; Sehr P; Pawlita M; Man S; Hickling JK; Fiander AN; Tristram A; Kitchener HC; Offringa R; Stern PL; Van Der Burg SH
    Clin Cancer Res; 2004 May; 10(9):2954-61. PubMed ID: 15131030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil.
    Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Booth M; Walboomers JM; Shah KV; Viscidi RP
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):341-7. PubMed ID: 8061584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors.
    Wieking BG; Vermeer DW; Spanos WC; Lee KM; Vermeer P; Lee WT; Xu Y; Gabitzsch ES; Balcaitis S; Balint JP; Jones FR; Lee JH
    Cancer Gene Ther; 2012 Oct; 19(10):667-74. PubMed ID: 22918471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
    Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
    PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.